7. Common Stock and Equity Payable (Details) |
1 Months Ended | 3 Months Ended | 12 Months Ended | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nov. 06, 2018
shares
|
Feb. 07, 2018
USD ($)
employee
$ / shares
shares
|
Oct. 19, 2018
$ / shares
shares
|
Sep. 30, 2018
USD ($)
shares
|
Aug. 29, 2018
USD ($)
$ / shares
shares
|
Jun. 30, 2018
USD ($)
$ / shares
shares
|
Feb. 23, 2018
shares
|
Dec. 21, 2017
USD ($)
employee
$ / shares
shares
|
Nov. 30, 2017
item
shares
|
Aug. 30, 2017
USD ($)
employee
$ / shares
shares
|
Aug. 22, 2017
USD ($)
employee
$ / shares
shares
|
Jul. 17, 2017
employee
shares
|
Jun. 27, 2017
USD ($)
employee
$ / shares
shares
|
Mar. 31, 2018
employee
shares
|
Dec. 31, 2018
USD ($)
|
Dec. 31, 2017
USD ($)
|
|
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | ||||||||||||||||
Stock-based compensation expense | $ 260,000 | |||||||||||||||
Shares issued | shares | 8,426 | 12,500 | 84,679 | 24,792 | 1,047,583 | 1,808 | 47,917 | 220,327 | 37,500 | 4,688 | 263,731 | 61,980 | 2,018,125 | |||
Shares Issued, Price Per Share | $ / shares | $ 0.78 | $ 1.20 | $ 0.48 | $ 0.48 | $ 0.75 | $ 0.41 | $ 0.48 | |||||||||
Proceeds from issuance of common stock, gross | $ 9,595 | $ 11,875 | $ 23,000 | $ 28,125 | $ 1,922 | $ 29,750 | ||||||||||
Common Stock For Cashless Transaction For Warrant Exercise | shares | 25,000 | 25,000 | ||||||||||||||
Common stock issued for warrant exercise | shares | 101,615 | 2,018,125 | ||||||||||||||
Offering Price | $ / shares | $ 1.00 | |||||||||||||||
Sale of common stock | shares | 5,775,000 | |||||||||||||||
Proceeds from sale of common stock | $ 5,775,000 | |||||||||||||||
Loss on conversion | $ 41,902 | |||||||||||||||
Number of employees that exercised vested stock options | employee | 1 | 1 | 1 | 1 | 1 | 1 | ||||||||||
Number of board members, issued stock from restricted stock agreement | employee | 4 | |||||||||||||||
Number of former board members, shares issued from restricted stock agreement | item | 2 | |||||||||||||||
Equity payable | $ 100,862 | $ 100,862 | ||||||||||||||
Principal | ||||||||||||||||
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | ||||||||||||||||
Face amount | 1,000,000 | |||||||||||||||
Accrued interest | ||||||||||||||||
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | ||||||||||||||||
Face amount | $ 47,583 |